Coming Soon
Learn about erythema nodosum (EN), also known as nodular erythema. This comprehensive resource covers EN diagnosis, clinical features, ICD-10 codes (L52), differential diagnosis, treatment, and management. Find information for healthcare professionals, including physicians, nurses, and medical coders, on documenting erythema nodosum in clinical notes and understanding its association with underlying conditions. Explore the latest research and best practices for accurate erythema nodosum diagnosis and optimal patient care.
Also known as
Erythema nodosum
Inflammation of subcutaneous fat causing red, tender nodules, typically on the shins.
Erythema nodosum with systemic lupus erythematosus
Erythema nodosum occurring as a manifestation of systemic lupus erythematosus.
Certain infectious and parasitic diseases
Erythema nodosum can be associated with various infections.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is Erythema Nodosum (EN) confirmed?
When to use each related code
| Description |
|---|
| Painful, red nodules on shins, often with fever, malaise. |
| Inflammation of subcutaneous fat, often with tender nodules or plaques. |
| Deep vein thrombosis causing leg pain, swelling, and tenderness. |
Coding EN requires specifying underlying cause (infection, medication, etc.) for accurate reimbursement and data analysis. Lack of specificity can lead to claim denials or skewed epidemiological data.
EN can be clinically similar to other inflammatory conditions, potentially leading to misdiagnosis and incorrect coding. CDI specialists should query physicians for clarification to ensure accurate code assignment.
Documenting EN severity (mild, moderate, severe) impacts treatment and potential resource utilization. Lack of clear documentation may affect code selection and lead to under- or over-coding.
Q: What are the key differential diagnoses to consider in a patient presenting with erythema nodosum-like lesions, and how can I differentiate them effectively?
A: Erythema nodosum (EN) can mimic several conditions, making accurate diagnosis crucial. Key differentials include Sweet syndrome, erythema induratum, deep vein thrombosis, cellulitis, and panniculitis. Differentiating EN requires a thorough clinical evaluation, considering factors like lesion distribution (typically pretibial), patient history (recent infections, medications, inflammatory bowel disease), and associated symptoms (fever, arthralgia). Biopsy can be helpful in challenging cases, revealing septal panniculitis with mixed inflammatory infiltrate in EN. Consider implementing a structured approach to evaluating patients with EN-like lesions to ensure accurate diagnosis and appropriate management. Explore how imaging studies, like ultrasound or MRI, can aid in differentiating EN from other conditions.
Q: Beyond NSAIDs and rest, what effective management strategies are available for patients with persistent or severe erythema nodosum, especially when underlying causes are identified?
A: While nonsteroidal anti-inflammatory drugs (NSAIDs) and rest are often the first line of management for erythema nodosum, persistent or severe cases, especially those linked to specific underlying conditions, may require additional interventions. If an infection like streptococcal pharyngitis is identified, appropriate antibiotic therapy is crucial. For inflammatory bowel disease-associated EN, optimizing IBD management can improve EN symptoms. In cases of sarcoidosis or Behcet's disease, systemic corticosteroids or other immunosuppressive agents might be necessary. Potassium iodide can be considered for refractory cases. Learn more about the role of colchicine and other emerging therapies in managing refractory EN. Consider implementing a multidisciplinary approach, involving dermatologists, rheumatologists, or infectious disease specialists, to address complex cases.
Patient presents with complaints consistent with erythema nodosum (EN), also known as nodular erythema. The patient reports tender, erythematous nodules, predominantly located on the anterior shins. Symptoms onset was [duration] ago and is associated with [associated symptoms, e.g., fever, malaise, arthralgia]. Physical examination reveals multiple, raised, warm, and painful subcutaneous nodules measuring [size] cm in diameter, with overlying skin exhibiting a reddish-purple discoloration. No ulceration or drainage is observed. Differential diagnosis includes cellulitis, panniculitis, erythema induratum, and thrombophlebitis. Considering the patient's presentation and clinical findings, the diagnosis of erythema nodosum is favored. Laboratory investigations, including a complete blood count (CBC), erythrocyte sedimentation rate (ESR), and antistreptolysin O (ASO) titer, have been ordered to evaluate for underlying infectious or inflammatory causes. Initial management includes leg elevation, rest, compression stockings, and nonsteroidal anti-inflammatory drugs (NSAIDs) for pain management. Patient education provided regarding the self-limiting nature of the condition and potential recurrence. Follow-up scheduled in [duration] to monitor symptom resolution and discuss further management based on laboratory results and clinical response. ICD-10 code I73.1 is assigned for erythema nodosum. Treatment plan and coding subject to change pending further diagnostic evaluation.